Vanda Pharmaceuticals
VNDA
#8787
Rank
ยฃ0.17 B
Marketcap
ยฃ2.85
Share price
6.41%
Change (1 day)
-15.30%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): ยฃ0.23

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ3.45. In 2022 the company made an earnings per share (EPS) of ยฃ0.08941 a decrease over its 2021 EPS that were of ยฃ0.45.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.23151.98%
2022ยฃ0.08941-80%
2021ยฃ0.4539.53%
2020ยฃ0.32-80.18%
2019ยฃ1.62334%
2018ยฃ0.37-247.06%
2017-ยฃ0.25-19.05%
2016-ยฃ0.31-55.32%
2015-ยฃ0.70-347.37%
2014ยฃ0.28-156.72%
2013-ยฃ0.50-31.63%
2012-ยฃ0.73172.22%
2011-ยฃ0.27-238.46%
2010ยฃ0.19-119.7%
2009-ยฃ0.98-31.61%
2008-ยฃ1.44-31.32%
2007-ยฃ2.09-99.27%
2006-ยฃ288.7536045.14%
2005-ยฃ0.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ4.98-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ3.91-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.57-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.00-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.74-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.37-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ3.27-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA